{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:54:35Z","timestamp":1795046075790,"version":"4.10.2"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003495","name":"Hessian Ministry of Science and Research Arts and Culture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023685","name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023685","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111089","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:15:41Z","timestamp":1782918941000},"page":"111089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["TRPC5 as a modulator of TRPV1 signalling in pathological pain states"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6143-7556","authenticated-orcid":false,"given":"Christian","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-7488","authenticated-orcid":false,"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sisignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/annrheumdis-2015-208886","article-title":"Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation","volume":"76","author":"Alawi","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.111089_bib2","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1523\/JNEUROSCI.0893-09.2009","article-title":"TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization","volume":"29","author":"Alessandri-Haber","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111089_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/26331055231220340","article-title":"A comprehensive review on the regulatory action of TRP channels: a potential therapeutic target for nociceptive pain","volume":"18","author":"Anand","year":"2023","journal-title":"Neurosci Insights"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/j.pain.0000000000000458","article-title":"Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations","volume":"157","author":"Andrews","year":"2016","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111089_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41594-024-01299-2","article-title":"Structural basis of TRPV1 modulation by endogenous bioactive lipids","volume":"31","author":"Arnold","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111089_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2016.10.002","article-title":"Transient Receptor Potential Channels in neuropathic pain","volume":"32","author":"Basso","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111089_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf5567","article-title":"Odontoblast TRPC5 channels signal cold pain in teeth","volume":"7","author":"Bernal","year":"2021","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0896-6273(02)00802-4","article-title":"cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation","volume":"35","author":"Bhave","year":"2002","journal-title":"Neuron"},{"issue":"30","key":"10.1016\/j.neuropharm.2026.111089_bib9","doi-asserted-by":"crossref","first-page":"15236","DOI":"10.1073\/pnas.1905705116","article-title":"Trpc5 deficiency causes hypoprolactinemia and altered function of oscillatory dopamine neurons in the arcuate nucleus","volume":"116","author":"Blum","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111089_bib10","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.15252\/embj.201696369","article-title":"Heteromeric channels formed by TRPC1, TRPC4 and TRPC5 define hippocampal synaptic transmission and working memory","volume":"36","author":"Broker-Lai","year":"2017","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111089_bib11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1172\/JCI42143","article-title":"Some new insights into the molecular mechanisms of pain perception","volume":"120","author":"Brown","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111089_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s13238-010-0108-9","article-title":"Heteromerization of TRP channel subunits: extending functional diversity","volume":"1","author":"Cheng","year":"2010","journal-title":"Protein Cell"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111089_bib14","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1074\/jbc.M111.305045","article-title":"Heteromeric heat-sensitive transient receptor potential channels exhibit distinct temperature and chemical response","volume":"287","author":"Cheng","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1085\/jgp.200709731","article-title":"Thermosensitive TRPV channel subunits coassemble into heteromeric channels with intermediate conductance and gating properties","volume":"129","author":"Cheng","year":"2007","journal-title":"J. Gen. Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4062\/biomolther.2017.127","article-title":"Depolarizing effectors of bradykinin signaling in nociceptor excitation in pain perception","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.neuropharm.2026.111089_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111089_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev-biochem-032620-105738","article-title":"Sensory TRP channels in three dimensions","volume":"91","author":"Diver","year":"2022","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111089_bib18","doi-asserted-by":"crossref","first-page":"eaaw7935","DOI":"10.1126\/sciadv.aaw7935","article-title":"Cryo-EM structure of TRPC5 at 2.8-A resolution reveals unique and conserved structural elements essential for channel function","volume":"5","author":"Duan","year":"2019","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111089_bib19","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1073\/pnas.1517288113","article-title":"Understanding TRPV1 activation by ligands: insights from the binding modes of capsaicin and resiniferatoxin","volume":"113","author":"Elokely","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111089_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111089_bib22","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00424-014-1497-z","article-title":"Direct evidence for functional TRPV1\/TRPA1 heteromers","volume":"466","author":"Fischer","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111089_bib23","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1074\/jbc.M510301200","article-title":"Sensing of lysophospholipids by TRPC5 calcium channel","volume":"281","author":"Flemming","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.neuropharm.2026.111089_bib24","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1523\/JNEUROSCI.0202-04.2004","article-title":"Identification of a tetramerization domain in the C terminus of the vanilloid receptor","volume":"24","author":"Garcia-Sanz","year":"2004","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111089_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003962","article-title":"The role of transient receptor potential cation channels in Ca2+ signaling","volume":"2","author":"Gees","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1124\/jpet.123.001853","article-title":"12-(S)-Hydroxyeicosatetraenoic acid and GPR31 signaling in spinal cord in neuropathic pain","volume":"388","author":"Giancotti","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111089_bib27","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1073\/pnas.1110460109","article-title":"Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors","volume":"109","author":"Gregus","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111089_bib28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00406-024-01890-0","article-title":"TRPC4\/5 inhibitors: phase I results and proof of concept studies","volume":"275","author":"Grimm","year":"2025","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41598-017-00591-0","article-title":"The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity","volume":"7","author":"Hohmann","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111089_bib30","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","article-title":"Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances","volume":"97","author":"Hwang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cpmo.11","article-title":"Peripheral neuropathy in mouse models of diabetes","volume":"6","author":"Jolivalt","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111089_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain","volume":"29","author":"Julius","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191225","article-title":"Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice","volume":"13","author":"Just","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111089_bib35","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111089_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1744-8069-5-19","article-title":"Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors","volume":"5","author":"Kerstein","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2026.111089_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108727","article-title":"The TRPC5 receptor as pharmacological target for pain and metabolic disease","volume":"263","author":"Khare","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111089_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2026.111089_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-025-01588-w","article-title":"Direct crosstalk between GPCRs and ion channels via G proteins","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111089_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67024-9","article-title":"Molecular architecture of the human TRPC1\/C5 heteromeric channel","author":"Kim","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111089_bib41","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1523\/JNEUROSCI.1943-12.2013","article-title":"A sensory-labeled line for cold: TRPM8-expressing sensory neurons define the cellular basis for cold, cold pain, and cooling-mediated analgesia","volume":"33","author":"Knowlton","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111089_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2024.102447","article-title":"Targeting TRP channels for pain relief: a review of current evidence from bench to bedside","volume":"75","author":"Koivisto","year":"2024","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/db21-0711","article-title":"GPR40 activation abolishes diabetes-induced painful neuropathy by suppressing VEGF-A expression","volume":"71","author":"Konigs","year":"2022","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib44","doi-asserted-by":"crossref","first-page":"G604","DOI":"10.1152\/ajpgi.00069.2002","article-title":"TRPC5 as a candidate for the nonselective cation channel activated by muscarinic stimulation in murine stomach","volume":"284","author":"Lee","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-3959(00)00256-6","article-title":"Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain","volume":"86","author":"Levy","year":"2000","journal-title":"Pain"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111089_bib46","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1016\/j.cell.2024.06.001","article-title":"Loss of transient receptor potential channel 5 causes obesity and postpartum depression","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"issue":"7478","key":"10.1016\/j.neuropharm.2026.111089_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature12822","article-title":"Structure of the TRPV1 ion channel determined by electron cryo-microscopy","volume":"504","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111089_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.pmbts.2015.01.002","article-title":"Sensory TRP channels: the key transducers of nociception and pain","volume":"131","author":"Mickle","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ph9040072","article-title":"Nociceptive TRP channels: sensory detectors and transducers in multiple pain pathologies","volume":"9","author":"Mickle","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"issue":"50","key":"10.1016\/j.neuropharm.2026.111089_bib50","doi-asserted-by":"crossref","first-page":"50080","DOI":"10.1074\/jbc.M306619200","article-title":"Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway","volume":"278","author":"Mohapatra","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2016.04.138","article-title":"The interaction domains of transient receptor potential canonical (TRPC)1\/4 and TRPC1\/5 heteromultimeric channels","volume":"474","author":"Myeong","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111089_bib52","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","article-title":"Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation","volume":"152","author":"Nassini","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111089_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd3624","article-title":"The neuropathic pain market","volume":"11","author":"Nightingale","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111089_bib54","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1172\/JCI136621","article-title":"12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1","volume":"130","author":"Otto","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrd2757","article-title":"Transient receptor potential channels: targeting pain at the source","volume":"8","author":"Patapoutian","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111089_bib56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.pain.2013.01.003","article-title":"Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis","volume":"154","author":"Paterson","year":"2013","journal-title":"Pain"},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2026.111089_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0143-4160(03)00055-1","article-title":"TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels","volume":"33","author":"Plant","year":"2003","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00018-024-05417-7","article-title":"Functional determinants of lysophospholipid- and voltage-dependent regulation of TRPC5 channel","volume":"81","author":"Ptakova","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111089_bib59","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1101\/gad.174060.111","article-title":"A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain","volume":"25","author":"Puram","year":"2011","journal-title":"Genes Dev."},{"issue":"42","key":"10.1016\/j.neuropharm.2026.111089_bib60","doi-asserted-by":"crossref","first-page":"26414","DOI":"10.1073\/pnas.1922618117","article-title":"Chronicling changes in the somatosensory neurons after peripheral nerve injury","volume":"117","author":"Raghuraman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111089_bib61","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"49","key":"10.1016\/j.neuropharm.2026.111089_bib62","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.1223-20.2020","article-title":"Lysophospholipids contribute to oxaliplatin-induced acute peripheral pain","volume":"40","author":"Rimola","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111089_bib63","series-title":"TRPV1 Receptors and Signal Transduction","author":"Rosenbaum","year":"2007"},{"issue":"23","key":"10.1016\/j.neuropharm.2026.111089_bib64","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1128\/MCB.20.23.8720-8730.2000","article-title":"8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein","volume":"20","author":"Rowan","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"595","key":"10.1016\/j.neuropharm.2026.111089_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd7702","article-title":"Transient receptor potential canonical 5 mediates inflammatory mechanical and spontaneous pain in mice","volume":"13","author":"Sadler","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00424-005-1467-6","article-title":"Homo- and heteromeric assembly of TRP channel subunits","volume":"451","author":"Schaefer","year":"2005","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111089_bib67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111089_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2025.138413","article-title":"Differential expression of TRPV1 and TRPM8 in the mouse trigeminal ganglion and spinal dorsal root ganglion","volume":"868","author":"Shao","year":"2025","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111089_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.plefa.2016.03.001","article-title":"Beyond the classic eicosanoids: Peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation","volume":"111","author":"Shapiro","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111089_bib71","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.25m15868","article-title":"Efficacy, tolerability, and safety of TRPC4\/5 Inhibitor BI 1358894 in patients with major depressive disorder and inadequate response to antidepressants: a phase 2 randomized, Placebo-Controlled, parallel group, dose-ranging trial","volume":"86","author":"Shelton","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111089_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.plipres.2013.11.002","article-title":"TRP-channels as key integrators of lipid pathways in nociceptive neurons","volume":"53","author":"Sisignano","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"6894","key":"10.1016\/j.neuropharm.2026.111089_bib73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature00894","article-title":"TRPV3 is a temperature-sensitive vanilloid receptor-like protein","volume":"418","author":"Smith","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111089_bib74","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63429","article-title":"Structural basis for human TRPC5 channel inhibition by two distinct inhibitors","volume":"10","author":"Song","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111089_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2202-12-120","article-title":"Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain","volume":"12","author":"Su","year":"2011","journal-title":"BMC Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111089_bib76","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.bbamem.2015.03.022","article-title":"TRP channels interaction with lipids and its implications in disease","volume":"1848","author":"Taberner","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2026.111089_bib77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2004.07.076","article-title":"Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons","volume":"498","author":"Tang","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111089_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040442","article-title":"Transient receptor potential canonical 5 (TRPC5): regulation of heart rate and protection against pathological cardiac hypertrophy","volume":"14","author":"Thakore","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib79","article-title":"TRPV1 and thermosensitivity","volume":"75","author":"Tominaga","year":"2025","journal-title":"J. Physiol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111089_bib80","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.ekir.2021.07.006","article-title":"Safety and efficacy of GFB-887, a TRPC5 channel inhibitor, in patients with focal segmental glomerulosclerosis, treatment-resistant minimal change disease, or diabetic nephropathy: TRACTION-2 trial design","volume":"6","author":"Walsh","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.neuropharm.2026.111089_bib81","article-title":"Impact of Dose, sex, and strain on oxaliplatin-induced peripheral neuropathy in mice","volume":"2","author":"Warncke","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"issue":"22","key":"10.1016\/j.neuropharm.2026.111089_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214274","article-title":"The FKBP51 inhibitor SAFit2 restores the pain-relieving C16 dihydroceramide after nerve injury","volume":"23","author":"Wedel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12974-022-02615-7","article-title":"SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain","volume":"19","author":"Wedel","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib84","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-023-38281-3","article-title":"Molecular architecture of the galpha(i)-bound TRPC5 ion channel","volume":"14","author":"Won","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111089_bib85","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1210\/en.2011-0141","article-title":"Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels","volume":"152","author":"Xie","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2026.111089_bib86","series-title":"Bradykinin Receptor Expression and bradykinin-mediated Sensitization of Human Sensory Neurons","author":"Yi","year":"2023"},{"key":"10.1016\/j.neuropharm.2026.111089_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1744-8069-4-61","article-title":"The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant","volume":"4","author":"Yu","year":"2008","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111089_bib88","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111089_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166914","article-title":"Structural pharmacology of TRP channels","volume":"433","author":"Zhao","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111089_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1085\/jgp.200309002","article-title":"G-protein-gated TRP-like cationic channel activated by muscarinic receptors: effect of potential on single-channel gating","volume":"123","author":"Zholos","year":"2004","journal-title":"J. Gen. Physiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111089_bib91","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbalip.2018.03.012","article-title":"The oxidized linoleic acid metabolite 12,13-DiHOME mediates thermal hyperalgesia during inflammatory pain","volume":"1863","author":"Zimmer","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"44","key":"10.1016\/j.neuropharm.2026.111089_bib92","doi-asserted-by":"crossref","first-page":"18114","DOI":"10.1073\/pnas.1115387108","article-title":"Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system","volume":"108","author":"Zimmermann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:24:02Z","timestamp":1786076642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":91,"alternative-id":["S0028390826002637"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111089","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRPC5 as a modulator of TRPV1 signalling in pathological pain states","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111089"}}